Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Tuesday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 price objective on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Price Performance

Shares of NASDAQ RKDA opened at $5.90 on Tuesday. The stock has a fifty day moving average price of $3.90 and a 200 day moving average price of $3.25. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $10.31. The company has a market cap of $8.05 million, a PE ratio of -1.38 and a beta of 1.18.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.